148 related articles for article (PubMed ID: 2413769)
41. Effect of somatostatin and octreotide acetate on OP-CCK-stimulated exocrine secretion in the denervated canine pancreas.
Garvin PJ; Burton FR; Reese JC; Dysarz FA; Lingle D; Niehoff ML; Pandya PK; Presti ME
Pancreas; 1996 Oct; 13(3):304-10. PubMed ID: 8884853
[TBL] [Abstract][Full Text] [Related]
42. Effect of a Rab3A effector domain-related peptide, CCK, and EGF in permeabilized pancreatic acini.
Zeuzem S; Stryjek-Kaminska D; Caspary WF; Stein J; Piiper A
Am J Physiol; 1994 Sep; 267(3 Pt 1):G350-6. PubMed ID: 7524341
[TBL] [Abstract][Full Text] [Related]
43. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
44. The action of synthetic secretin, cholecystokinin-octapeptide and combinations of these hormones on the secretion of the isolated perfused rat pancreas.
Sommer H; Kasper H
Hepatogastroenterology; 1981 Dec; 28(6):311-5. PubMed ID: 6178671
[TBL] [Abstract][Full Text] [Related]
45. Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini.
Younes M; Jensen RT; Gardner JD
Biochim Biophys Acta; 1987 Oct; 930(3):410-8. PubMed ID: 2443185
[TBL] [Abstract][Full Text] [Related]
46. Interaction of glucagon-like peptide-1 (7-36)amide and cholecystokinin-8 in the endocrine and exocrine rat pancreas.
Fehmann HC; Göke B; Weber V; Göke R; Trautmann ME; Richter G; Arnold R
Pancreas; 1990 May; 5(3):361-5. PubMed ID: 1693001
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
Akiyama T; Tachibana I; Otsuki M
Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
[TBL] [Abstract][Full Text] [Related]
48. Selective release of somatostatin by calcitonin gene-related peptide and influence on pancreatic secretion.
Debas HT; Nelson MT; Bunnett NW; Mulvihill SJ
Ann N Y Acad Sci; 1992 Jun; 657():289-98. PubMed ID: 1379016
[TBL] [Abstract][Full Text] [Related]
49. Bioassay of plasma cholecystokinin in rat and human: inhibition of protein synthesis prevents the decrease in the sensitivity and responsiveness of isolated rat pancreatic acini to CCK-8.
Otsuki M; Okabayashi Y; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Baba S
Pancreas; 1989; 4(4):447-51. PubMed ID: 2474813
[TBL] [Abstract][Full Text] [Related]
50. Effects of phorbol ester on cholecystokinin octapeptide-evoked exocrine pancreatic secretion in the rat.
Francis LP; Camello PJ; Singh J; Salido GM; Madrid JA
J Physiol; 1990 Dec; 431():27-37. PubMed ID: 1712842
[TBL] [Abstract][Full Text] [Related]
51. Pancreastatin inhibits pancreatic enzyme secretion by presynaptic modulation of acetylcholine release.
Herzig KH; Louie DS; Tatemoto K; Chung OY
Am J Physiol; 1992 Jan; 262(1 Pt 1):G113-7. PubMed ID: 1370747
[TBL] [Abstract][Full Text] [Related]
52. GIP potentiates CCK stimulated pancreatic enzyme secretion: correlation of anatomical structures with the effects of GIP and CCK on amylase secretion.
Mueller MK; Scheck T; Dreesmann V; Miodonski A; Goebell H
Pancreas; 1987; 2(1):106-13. PubMed ID: 2437570
[TBL] [Abstract][Full Text] [Related]
53. Secretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in mice.
DiMagno MJ; Hao Y; Tsunoda Y; Williams JA; Owyang C
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G428-36. PubMed ID: 14551061
[TBL] [Abstract][Full Text] [Related]
54. Stimulation of rat pancreatic exocrine secretion by cocaine- and amphetamine-regulated transcript peptide.
Cowles RA; Segura BJ; Mulholland MW
Regul Pept; 2001 May; 99(1):61-8. PubMed ID: 11257316
[TBL] [Abstract][Full Text] [Related]
55. Amylase secretion by isolated pancreatic acini after chronic cholecystokinin treatment in vivo.
Otsuki M; Williams JA
Am J Physiol; 1983 Jun; 244(6):G683-8. PubMed ID: 6190411
[TBL] [Abstract][Full Text] [Related]
56. Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin.
Masuda M; Tomita H; Okubo K; Miyasaka K
J Auton Nerv Syst; 1994 Dec; 50(2):131-8. PubMed ID: 7884153
[TBL] [Abstract][Full Text] [Related]
57. Effects of synthetic human pancreatic polypeptide, synthetic bovine pancreatic polypeptide, and the C-terminal hexapeptide on pancreatic somatostatin and glucagon secretion in the rat.
Trimble ER; Gerber PG; Renold AE
Diabetes; 1982 Feb; 31(2):178-81. PubMed ID: 6130016
[TBL] [Abstract][Full Text] [Related]
58. In vivo activities of peptide and pseudo-peptide analogs of the C-terminal octapeptide of cholecystokinin on pancreatic secretion in the rat.
Nagain C; Rodriguez M; Martinez J; Rozé C
Peptides; 1987; 8(6):1023-8. PubMed ID: 3441441
[TBL] [Abstract][Full Text] [Related]
59. A new biological contribution of cyclo(His-Pro) to the peripheral inhibition of pancreatic secretion.
Fragner P; Presset O; Bernad N; Martinez J; Roze C; Aratan-Spire S
Am J Physiol; 1997 Dec; 273(6):E1127-32. PubMed ID: 9435528
[TBL] [Abstract][Full Text] [Related]
60. Galanin inhibits pancreatic amylase secretion in the pentobarbital-anesthetized rat.
Yagci RV; Alptekin N; Zacharia S; Coy DH; Ertan A; Rossowski WJ
Regul Pept; 1991 Jul; 34(3):275-82. PubMed ID: 1718017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
